| Literature DB >> 25435123 |
Wendy Landier1, Saro Armenian1, Smita Bhatia2.
Abstract
Treatment for childhood cancer with chemotherapy, radiation and/or hematopoietic cell transplant can result in adverse sequelae that may not become evident for many years. A clear understanding of the association between therapeutic exposures and specific long-term complications, and an understanding of the magnitude of the burden of morbidity borne by childhood cancer survivors, has led to the development of guidelines to support lifelong risk-based follow up for this population. It is important to develop interventions to reduce the impact of treatment-related late effects on morbidity and mortality and to continue research regarding the etiopathogenesis of therapy-related cancers and other late effects.Entities:
Keywords: Cancer; Childhood; Late effects; Treatment
Mesh:
Substances:
Year: 2014 PMID: 25435123 DOI: 10.1016/j.pcl.2014.09.017
Source DB: PubMed Journal: Pediatr Clin North Am ISSN: 0031-3955 Impact factor: 3.278